Common Stock, Shares, Outstanding of Inozyme Pharma, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inozyme Pharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • Inozyme Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2025 was 64,470,243, a 4.3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Inozyme Pharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 64,470,243 +2,653,734 +4.3% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 64,240,198 +2,471,427 +4% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 64,179,095 +2,418,347 +3.9% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 62,071,965 +15,692,877 +34% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 61,816,509 +18,051,024 +41% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 61,768,771 +21,374,408 +53% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 61,760,748 +21,366,385 +53% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 46,379,088 +6,282,012 +16% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 43,765,485 +19,947,074 +84% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 40,394,363 +16,725,616 +71% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 40,394,363 +16,729,616 +71% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 40,097,076 +16,526,483 +70% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 23,818,411 +344,708 +1.5% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 23,668,747 +283,778 +1.2% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 23,664,747 +299,896 +1.3% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 23,570,593 +22,225,889 +1653% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 23,473,703 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 23,384,969 +22,180,339 +1841% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 23,364,851 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 1,344,704 30 Jun 2020 10-Q 03 Sep 2020 2020 Q2
Q4 2019 1,204,630 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.